Epstein-Barr virus is a human gammaherpesvirus that infects and establishes latency in
Introduction
Epstein-Barr virus (EBV) is the aetiological agent of infectious mononucleosis and is associated with several forms of human cancer (reviewed by Cohen, 1999 ; Kieff, 1996b ; Sugden, 1994) . In both in vitro-immortalized lymphocytes (LCLs) and several malignant cell types, the 172 kb genome persists as an autonomously replicating episome that expresses a small subset of its genes. EBV induces and controls cellular proliferation through the expression of ten viral genes encoding six nuclear proteins (EBNAs 1, 2, 3A, 3B, 3C and LP), three membrane proteins (LMP1, LMP2A and LMP2B) and two small RNAs (Kieff, 1996a ; Miller, 1990 ; Rowe, 1999) . In vivo, EBV establishes a persistent latent infection in a population of B cells bearing markers of a non-activated resting memory subset (Miyashita et al., 1997 ; Babcock et al., 1998 Babcock et al., , 1999 Babcock et al., , 2000 . Latently infected B cells in situ possess very low numbers of virus Author for correspondence : David Rowe.
Fax j1 412 383 7490. e-mail rowe1!pitt.edu episomes that express the mRNA for LMP2A (Khan et al., 1996 ; Miyashita et al., 1995 ; Qu & Rowe, 1992 ; Rowe, 1999) .
The LMP2 gene encodes two messages of 2n0 and 1n7 kb in length, which are produced by alternative promoter usage (Laux et al., 1988 ; Sample et al., 1989) . The longer message encodes LMP2A, while the shorter message is initiated from a promoter, approximately 5 kb downstream, that is bidirectional and responsible for LMP1 expression in the leftward direction and LMP2B expression in the rightward direction (Laux et al., 1988 ; Rowe, 1999) . The mRNAs share eight 3h exons but have unique 5h exons. Initial transcripts cross the fused terminal repeat region of the virus episome with the promoters and 5h exons located near the right end of the genome and the common exons located at the left end of the genome (Laux et al., 1988 ; Sample et al., 1989) . The eight common exons encode 12 membrane-spanning segments connected by short loops and ending with a 27 aa cytoplasmic C-terminal domain. (Kieff, 1996b ; Longnecker, 2000) . The difference between the two isoforms is that LMP2A has an Nterminal 119 aa cytoplasmic-signalling domain that is not present in LMP2B.
The restriction of viral gene expression to LMP2A in situ suggests that the protein may have a key role in either the establishment or the maintenance of latency and\or the reactivation of productive infection from the latent state. The focus of most studies has been on the LMP2A product. To date, there has not been a comprehensive phenotypic analysis of the LMP2B isoform. This is partly because of the hydrophobic character of LMP2 proteins. The rabbit polyclonal sera and rat monoclonal antibodies that have been produced have specificities for epitopes in the cytoplasmic domain (Fruehling et al., 1996 ; Longnecker et al., 1991 ; Rowe et al., 1990) . No sera have been made that unequivocally detect LMP2B. Although mRNAs for both proteins are expressed in immortalized B cells, genetic analyses of the LMP2 gene have shown that neither product is required for immortalization of B cells by the virus. Three different virus recombinants (a stop codon in place of residue 19 in the LMP2A sequence allowing LMP2B expression only, a stop codon at residue 260, truncating both LMP2 proteins after the fifth membranespanning segment, and a deletion between residues 120 and 260 that allows only LMP2A cytoplasmic domain expression) gave rise to essentially normal LCLs (Longnecker et al., 1992 (Longnecker et al., , 1993 Yates, 1993) . Recent studies with pure LMP2A-knockout viruses as inocula for immortalization of primary B cells revealed no discernable defect in their ability to generate immortalized cell lines (Konishi, 2001) . Virus mutants that interrupt LMP2A exon1 and leave LMP2B intact and, presumably, expressed, indicate that LMP2B possesses no independent role in producing the B cell receptor signalling blockade phenotype of the LMP2 gene.
While the significance of LMP2B and its role in pathogenesis remain unclear, homology studies comparing the LMP2 gene of EBV with that of rhesus and baboon lymphocryptoviruses have revealed that the ability to make the LMP2B transcript is conserved (Rivailler et al., 1999) . This implies that there is an as yet unrecognized role for LMP2B in the EBV life cycle. In this report, we describe the initial characterization of the localization of the LMP2B protein in transiently transfected cells. LMP2B cDNA expression vectors containing N-or C-terminal enhanced green fluorescent protein (EGFP) or DsRed protein fusions were constructed to allow detection of LMP2B protein expression in living cells. Conventional and confocal fluorescence microscopy revealed that LMP2B localized to perinuclear regions in transiently transfected cells and co-localized with LMP2A.
Methods
Cell lines and cell culture. BJAB is an EBV-negative Burkitt lymphoma cell line ; B95-8CR is an in vitro-established LCL (a gift from A. Rickinson, University of Birmingham, Birmingham, UK) ; 293T is a human embryonic kidney cell line containing the SV40 large T antigen. All B cell lines were maintained in complete RPMI 1640 medium containing 10 % inactivated foetal bovine serum, 2 mM glutamine, 60 µg\ml penicillin and 200 µg\ml streptomycin at 37 mC in 5% CO # .
293T cells were grown in complete Dulbecco's modified Eagle's medium (DMEM) under identical growth conditions.
Construction of recombinant LMP2 plasmids. DNA fragments encoding full-length LMP2A or LMP2B were amplified by PCR from B95-8 cDNA using the following primers : Exon1 (5h CCCCTCGAGCT-CAAGCTTACTACCAT GGGGTCCCTAGAA 3h) or Exon2 (5h CC-CCTCGAGCTCAAGCTTACTAGTATGAA TCCAGTATGCCTG 3h) with LMP2 C-term (5h GCGCGGTACCACAGTGTTGCGATATGG 3h), respectively. Both 5h primers contain an Xho1 restriction site (underlined) and the 3h primer contains a Kpn1 restriction site. PCR products were digested with Xho1\Kpn1 and ligated into pN " EGFP, pC " EGFP or pN " DsRed mammalian expression vectors (Clontech). FLAG epitope-tagged LMP2-expressing vectors were constructed by a multistep cloning approach. Oligonucleotides encoding the FLAG epitope were used to incorporate an iterated 3i FLAG into the open reading frame (ORF) of LMP2. All constructs were sequenced to ensure the correct alignment of the LMP2 ORFs after assembly.
Transfections. All DNA used for transfection were banded on CsCl # equilibrium density gradients. For B cell lines, 5i10' cells were washed once in PBS and resuspended at room temperature in 0n4 ml of serum-free, phenol red-free RPMI 1640 containing 20 µg pN " EGFP-LMP2A or pN " DsRed-LMP2B. Cells were transferred to a sterile electroporation cuvette (0n4 cm electrode gap) (Invitrogen) and pulsed twice ; the multiporator (Eppendorf) was set at 400 V for 100 µs. Cells were then settled for 10 min at 37 mC and diluted into 10 ml of complete phenol red-free RPMI 1640. For 293T cells, confluent T225 flasks were trypsinized with 10i trypsin (Gibco) and washed. The cells were then adjusted to a concentration of 1i10( cells\ml in serum-free, phenol redfree DMEM. Approximately 4i10' cells were then pulsed twice in a 0n4 cm cuvette containing 20 µg of plasmid in a multiporator (Eppendorf) set at 280 V for 100 µs. Cells were settled for 10 min at 37 mC and approximately 0n1i10' cells were seeded into chamber slides.
Antibodies and immunofluorescence. Anti-human IgM antibodies for immunofluorescence were purchased from Biosource International. Anti-human CD19 (BD Biosciences), LAMP-1, EEA-1, γ-adaptin, PDI (Transduction Laboratories) and BIP (StressGen Biotechnologies) antibodies were also purchased. The rat monoclonal antibody anti-human LMP2A (14B7) was kindly provided by R. Longnecker (NorthWestern University, Chicago, USA ). Alexa-fluor 488 and 594 secondary antibodies were purchased from Molecular Probes. Mounting media containing DAPI was purchased from Vector Laboratories. Immunofluorescence was performed by washing transiently transfected B cells twice in PBS. Cells were then fixed to microscope slides using a cytospin (Shanndon) set at 500 r.p.m. for 5 min. Slides were dried for 1 h at room temperature in the dark and fixed in freshly prepared 2-4 % paraformaldehyde, pH 7n4, for 15 min at room temperature. Samples were blocked for 1 h in blocking buffer containing 0n5 % BSA, 0n1 % NaN $ and 0n1 % saponin. Primary antibodies were incubated at varying dilutions in blocking buffer for 30 min at 4 mC. Secondary antibodies were diluted in blocking buffer (1 : 2000 dilution) for 30 min at 4 mC. Slides were washed and mounted with Vectashield-mounting medium containing DAPI (Vector Laboratories). For cell surface immunostaining, live cells were chilled on ice for 10 min and incubated with anti-FLAG antibody (Sigma) for 30 min at 4 mC. Cells were washed in cold blocking buffer, fixed in 2 % phosphonoformic acid and incubated with Alexa-fluor secondary antibodies (Molecular Probes).
Microscopy. Slides were examined with a Nikon E600 equipped with a SPOTII CCD digital camera. Digital images were composed using  software (Universal Imaging). Confocal digital images were taken using BioRad  software coupled with a BioRad BACG RadiancePLUS confocal microscope system. Integrated average pixel area and intensity values for individual cells were measured using  software.
Results

Expression of fluorescent LMP2B fusion proteins
The hydrophobic sequences of transmembrane segments make poor epitopes for the generation of specific antisera. Our attempts to produce anti-peptide antisera that recognize the loop regions connecting LMP2 transmembrane segments have yielded high titre antibodies that recognize the peptide but not the proteins. To address these problems of detection, expression vectors with LMP2B proteins bearing fluorescent tags and epitope tags were generated so that LMP2B could be easily detected and tracked within transfected cells. LMP2A and LMP2B sequences were amplified by PCR from B95-8 cDNA and cloned into pN " EGFP, pC " EGFP or pN " DsRed mammalian expression vectors to create LMP2 protein fusion constructs with N-and C-terminal fluorescent tags. In addition, a 3i FLAG epitope tag was introduced into the first extracellular loop of LMP2, either separately or in combination with the fluorescent tags. Constructs with 1i or 2i FLAG and haemagglutinin tags were also made but only the 3i FLAG was detectable in the internal loop1 site (data not shown). The coding sequences of all of the recombinant LMP2 ORFs were verified by sequencing after construction.
Constructs with DsRed or EGFP fused to the C terminus of LMP2B (LMP2B-DsRed and LMP2B-EGFP) or the base vectors (pDsRed and pN " EGFP) were transiently transfected into BJAB (lymphocyte) and 293T (epithelial) cells (Fig. 1) . Protein expression was examined 12, 24, 48 and 96 h posttransfection. Cells were viewed both live and after fixation in 2 % paraformaldehyde. At 24 h post-transfection, transient expression from the control vectors cells was detected as a uniform bright red or green fluorescence that filled the entire volume of the cell and whose appearance was unaltered by fixation ( Fig. 1) . Only the DsRed fluorescence is shown as the localization of EGFP fusions was identical. LMP2B-DsRedexpressing cells, both live and fixed, displayed from one to several distinct patches of fluorescence, which consistently appear to be located proximal to the nucleus. Electroporation typically yielded 10-15 % positive expressing B cells and 60-80 % positive expressing 293T cells after 72 h of incubation. Fluorescence was detectable as early as 12 h posttransfection and persisted for more than 2 weeks without selection. At the earliest time-points, the level of LMP2B fluorescence was weaker in intensity but localized to patches in the intracellular perinuclear region. Protein localization was not altered, irrespective of the time post-transfection that the observations were made, the level of LMP2B-DsRed fluorescence in a cell or the type of cell transfected. The expression vectors contain a G418 resistance selectable marker but cells lines expressing LMP2B-DsRed have been difficult to establish and maintain. Resistant cells lines have a tendency to loose LMP2B-DsRed fluorescence and need to be flow-sorted to retain a high proportion of positive cells.
Perinuclear localization of recombinant LMP2B proteins
Perinuclear localization of LMP2B-DsRed contrasts with the view of LMP2 proteins as residents of the plasma membrane. One possibility was that there might be a significant difference in localization between LMP2A and LMP2B. It was also possible that the localization of LMP2B was an artefact and a consequence of LMP2B-DsRed having a C-terminal fluorescent tag. A series of transient co-transfections were performed in BJAB and 293T cells using LMP2-DsRed and expression vectors with the different tags (LMP2B-EGFP) and also tags attached at opposite ends (EGFP-LMP2B) of the LMP2B molecule. Live cell fluorescence of co-expressing cells revealed that LMP2B-DsRed co-localized with LMP2B recombinants containing either N-or C-terminal EGFP fusions (Fig.  2) . Image analysis of the area\intensity-averaged overlap was greater than 95 % and often in the range of 99 %. Neither the type of the tag nor the position of the tag at either end of the molecule changed the perinuclear pattern of LMP2B fluorescence.
It was still possible that the presence of fluorescent tags caused LMP2B fusions to take on an anomalous non-plasma membrane localization. LMP2B containing a 3i iteration of an octapeptide FLAG epitope tag in the first extracellular loop of the transmembrane domain was constructed. 293T or BJAB cells singly transfected with the plasmids expressing the FLAG-tagged LMP2B showed similar patterns of perinuclear fluorescence as the EGFP-and DsRed-tagged molecules (data not shown). Cells were transiently co-transfected with FLAGtagged LMP2B proteins and an LMP2B that had EGFP fused to either the N-or the C-terminal domain. When either 293T or BJAB cells were fixed and immunostained for the FLAG epitope, the co-transfected cells showed 90 % co-localization of the EGFP-tagged LMP2B and the epitope-tagged LMP2B species by image analysis of the area\intensity-averaged overlap (Fig. 3A, B) . Only the 293T co-localizations are shown as the BJAB results were identical.
BJAB cells expressing an LMP2B construct that contained both the N-terminal epitope tag and the C-terminal DsRed tag on the same molecule showed a complete overlap of the green immunofluorescence from the loop1 3i FLAG tag and the red autofluorescence of the C-terminal DsRed tag (Fig. 3C) . This is the expected finding only when the red and green fluorescence is coming from intact proteins. When the antibody probe for the 3i FLAG was applied to live, chilled, non-permeabilized cells to detect surface expression of the FLAG epitopes, no anti-FLAG fluorescence was observed (Fig. 3D) . Similar results were obtained with 293T cells. In summary, these results indicated that neither the presence of fluorescent tags at the ends of LMP2B nor the sequence composition of the fluorescent domain seemed to be responsible for directing LMP2B molecules to a perinuclear localization. The presence of a FLAG epitope tag in loop1 of LMP2B did not affect localization. Perinuclear localization in lymphocytes and epithelial cells had the same patchy appearance.
LMP2B co-localization with LMP2A
Because of the high degree of structural relatedness between the LMP2A and LMP2B isoforms, it was anticipated that the molecules should localize to the same cellular compartment. However, the perinuclear localization of LMP2B contrasted with the expected plasma membrane localization of LMP2A. We therefore conducted an analysis of LMP2A membrane localization and assessed whether the two proteins had the same or different fluorescence patterns when coexpressed in our fluorescent molecule-tagging system. For these experiments, LMP2A bore a C-terminal EGFP tag and LMP2B bore a C-terminal DsRed tag. This allowed us to visualize the localization of the two proteins together in live cells in the absence of any potential fixation artefacts (Fig. 4A) . Only the results for BJAB cells are shown as they were identical to the results for 293T cells. Co-transfections yielded BACI Fig. 2 . Co-localization of LMP2B-DsRed with N-and C-termini EGFPtagged LMP2B. Green fluorescence of LMP2B with EGFP fused to either the N or the C terminus overlaps the red fluorescence of LMP2B-DsRed in live transiently transfected cells. BJAB (A, B) and 293T (C, D) cells were co-transfected with LMP2B containing a C-terminal DsRed tag (LMP2B-DsRed) and vectors containing EGFP fused to either the N or the C terminus. Red and green channels were digitally collected as separate images and merged in METAMORPH software. All micrographs were taken 24 h post-transfection. The average overlap of red (R) and green (G) signals was calculated using METAMORPH software and is expressed as a percentage of the area/intensity-averaged overlap. Bar, 5 µm.
a mixture of cells that were untransfected, singly transfected or doubly transfected on the same slide preparation. Localizations of LMP2A and LMP2B were not altered by the presence or Fig. 3 . Epitope-tagged LMP2B co-localizes with EGFP-tagged LMP2B. (A, B) N-terminal EGFP-fused LMP2B (EGFP-LMP2B) and C-terminal EGFP-fused LMP2B (LMP2B-EGFP) were co-transfected with loop1 3i FLAG epitope-tagged LMP2B into 293T cells. Fixed cells were probed for FLAG-tagged LMP2B using M2 anti-FLAG antibody (Sigma) and the red fluorescing Alexa-fluor 594 nm goat anti-mouse (Molecular Probes). (C, D) Fixed and live BJAB cells transiently expressing LMP2B-DsRed containing a 3i FLAG epitope tag in loop1 were stained for FLAG. The epitope was detected using M2 anti-FLAG antibody (Sigma) and the green fluorescing Alexa-fluor 488 nm goat anti-mouse antibody. Red and green channels were digitally collected as separate images and merged in METAMORPH software. All micrographs were taken 24 h post-transfection. Bar, 5 µm. A, B) . B95-8CR (EBVj) LCLs were transiently transfected with LMP2B-DsRed and probed for endogenous LMP2A. LMP2A was detected by epi-fluorescence (C) and confocal microscopy (D) using a rat monoclonal (14B7) and Alexa-fluor 488 nm goat anti-rat antibodies. All images were taken 24 h posttransfection. Bar, 5 µm.
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absence of the other isoform or by paraformaldehyde fixation (Fig. 4B) . Both proteins displayed a perinuclear localization in singly transfected cells and co-localized to the same patches when they were co-expressed. Analysis of the area\intensity-averaged overlap indicated that there was 99 % overlap of the two proteins in the transfected cells.
Since LMP2A can be detected as an untagged protein by immunofluorescence on virus-immortalized lymphocytes, it can serve as an important control for the use of the tagged molecules in localization studies. The pattern of immunofluorescence staining of endogenous LMP2A in B95-8CR cells (a B95-8 virus-immortalized adult lymphoblastoid cell line) was similar to the pattern of LMP2B-DsRed fluorescence in BJAB cells and was also typical of other LMP2A-expressing LCLs (data not shown). B95-8CR cells were transfected with the LMP2B-DsRed expression construct to compare the localization of endogenous LMP2A with co-expressed LMP2B.
In transfected cells, LMP2B co-localized with endogenous LMP2A in the perinuclear regions of B95-8CR cells (Fig. 4C) . Analysis of the area\intensity-averaged overlap indicated that 97 % of the transiently expressed LMP2B was associated with endogenously expressed LMP2A in these cells, while only 75 % of the endogenous LMP2A was co-localized with LMP2B. This suggested that a portion of LMP2A may be localizing to distinct compartments within the cell, possibly the plasma membrane. Confocal images through the middle planes of optically sectioned co-transfected cells confirmed the extent of the LMP2B overlap with the endogenous LMP2A (Fig. 4D) .
A probe for LMP2A protein at the surface of live cells with loop1 epitope tags
There has never been a direct observation of LMP2A protein at the surface of live cells because no appropriate BADA LMP2B localizes to perinuclear regions LMP2B localizes to perinuclear regions Fig. 5 . Localization of LMP2A truncation mutants to the cell surface. 293T cells transiently expressing LMP2A-EGFP, LMP2A-TM2 or LMP2A-TM6 truncation mutants (schematic) were chilled and probed for FLAG at the plasma membrane of live cells with anti-FLAG antibodies. Cells were subsequently fixed and incubated with secondary antibodies. Red and green digital micrographs were collected separately and combined using  software. Bar, 5 µm. reagent for detecting the molecules from outside the cell has been produced. We constructed LMP2A loop1-tagged protein expression vectors for this purpose. After transfection into BJAB or 293T cells, unpermeabilized cells were probed with anti-FLAG antibody. No immunofluorescence was detected (Fig. 5A ). Permeabilized cells from the same transfections gave readily detectable FLAG fluorescence signals. A survey of 293T and BJAB cells transfected with a loop1 3i FLAGtagged LMP2A-EGFP fusion to easily identify LMP2A-expressing cells was conducted but no evidence for surface staining for LMP2A was detected (data not shown).
It was possible that some conformational feature of the FLAG-tagged molecule prevented the epitope from being detected at the surface of live cells. The restriction would then have to be relieved by fixation with paraformaldehyde. On the other hand, confocal sectioning (Fig. 4D ) and other localization Fig. 6 . Subcellular localization of DsRed-LMP2B (red) using cell compartment markers. BJAB cells were transiently transfected with LMP2B-DsRed, fixed and probed with a panel of antibodies specific for markers of intracellular compartments (green). Cells were analysed 24 h post-transfection and probed for CD19 (surface marker), LAMP-1 (lysosomes), EEA-1 (early endosomes), γ-adaptin (trans-Golgi network) and BIP-1 (endoplasmic reticulum). Bar, 5 µm. studies were consistent with the possibility that there might be no protein on the surface to detect. Therefore, we made Cterminal truncation mutants of LMP2A, reasoning that intracellular retention signals were likely to be located within the 12 transmembrane segments of the transmembrane domain. Disrupting these signals should abolish the intracellular D. T. Lynch, J. S. Zimmerman and D. T. Rowe D. T. Lynch, J. S. Zimmerman and D. T. Rowe Fig. 7 . Subcellular localization of LMP2A (red) in LCLs using cell compartment markers. B95-8CR cells were fixed and probed with a panel of antibodies specific for markers of intracellular compartments (green). Cells were analysed 24 h post-transfection and probed for CD19 (surface marker), LAMP-1 (lysosomes), EEA-1 (early endosomes), γ-adaptin (transGolgi network) and BIP-1 (endoplasmic reticulum). All micrographs were taken with a 60i oil objective lens. LMP2A was detected using a rat monoclonal (14B7) and Alexa-fluor 594 nm goat anti-rat antibodies. Bar, 5 µm.
retention of LMP2A and allow the protein to be trafficked to the surface. Six and ten transmembrane segments were removed from loop1 3i FLAG-tagged LMP2A-EGFP. These constructs were transfected into BJAB and 293T cells and live cells were probed for surface expression of LMP2A with anti-FLAG antibodies (Fig. 5B, C) . Compared to full-length LMP2A-EGFP, the fluorescence of EGFP in the truncation mutant-transfected cells was diffusely distributed throughout the cytoplasm. The anti-FLAG antibodies readily bound to the surface of the cells. Analysis of the area\intensity-averaged overlap indicated that 98 % of the truncated molecules were detected on the surface of transfected cells. These results show that the distribution and intracellular localization of LMP2A is governed, at least in part, by the transmembrane domain. When the loop1 tag is exposed on the surface of live cells, it is detectable by anti-FLAG antibodies.
Subcellular localization of LMP2B-DsRed
Immunofluorescence microscopy with a panel of antibodies specific for markers of intracellular compartments was used to investigate the localization of LMP2B-DsRed in transiently transfected BJAB cells. At 24 h post-transfection, cells were probed for CD19 (surface marker), LAMP-1 (lysosomes), EEA-1 (early endosomes), γ-adaptin (trans-Golgi network) and BIP-1 (endoplasmic reticulum) (Fig. 6) . The greatest overlap in fluorescence was between LMP2B-DsRed and γ-adaptin (a component of the trans-Golgi network). Analysis of the area\intensity-averaged overlap indicated that 80 % of LMP2B was associated with γ-adaptin. However, there were also significant amounts of γ-adaptin that were not associated with LMP2B. Partial co-localization was observed between LMP2B-DsRed and BIP-1 (the endoplasmic reticulum resident protein). There was also a partial overlap between LMP2B and the CD19 surface marker. There was no appreciable overlapping of fluorescence between LMP2B and the markers for endosomes or lysosomes. The pattern of immunofluorescence for all of the cellular compartment markers in LMP2B-expressing cells was essentially indistinguishable from the untransfected cells on the same slide, indicating that LMP2B expression did not appear to significantly alter the functioning of membrane trafficking within the transfected cells.
We analysed the localization of endogenous LMP2A in B95-8CR cells relative to the same collection of membrane compartment markers used for the assessment of LMP2B localization (Fig. 7) . Endogenous LMP2A in B95-8CR cells also co-localized with the trans-Golgi network marker γ-adaptin. Analysis of the area\intensity-averaged overlap indicated that 40 % of LMP2A was associated with γ-adaptin. There was also significant localization with EEA-1, the endosome marker. Analysis of the area\intensity-averaged overlap indicated that 60 % of LMP2A was associated with EEA-1. There was no significant co-localization with either the BIP-1 endoplasmic reticulum marker, the CD19 plasma membrane marker or the lysosome marker.
Optical sectioning of BJAB cells transiently expressing LMP2A-EGFP or LMP2B-DsRed by confocal microscopy was used to confirm the localization of epi-fluorescence. Cells were probed for CD19 (Fig. 8A) . No plasma membrane colocalization was observed between the cell surface marker CD19 and LMP2A. Similar results were obtained with 293T cells. Epi-fluorescence co-localization studies had suggested Fig. 8 . LMP2B co-localizes with intracellular CD19. Serial laser scanning confocal micrographs were taken of BJAB cells transiently transfected with that there was some overlap between the LMP2B fluorescence and CD19, despite the inability to detect any surface expression of FLAG-tagged LMP2B-DsRed. BJAB cells expressing LMP2B-DsRed and probed for CD19 were optically sectioned by confocal microscopy (Fig. 8B) . Serial Z-plane sections clearly delineated the plasma membrane localization of CD19 in the transfected cells and also showed that the pattern of LMP2B fluorescence was internal and did not colocalize with surface-expressed CD19. However, in every LMP2B-positive cell examined, there was an intracellular colocalized patch of CD19. Confocal microscopy was also used to confirm that the localization of LMP2B was perinuclear and that there was a significant co-localization with the trans-Golgi membrane marker γ-adaptin (Fig. 8C) . Z-Plane series demonstrated that a high degree of perinuclear co-localization between LMP2B and γ-adaptin occurs in BJAB cells transiently expressing LMP2B-DsRed. Confocal analysis of B95-8CR cells probed for both LMP2A and γ-adaptin revealed a similar pattern of co-localization (data not shown).
Discussion
It has been postulated previously that LMP2B may function as a negative regulator of LMP2A because of the nearly identical structure and the critical absence of the signalling domain (Longnecker, 2000 ; Longnecker et al., 1992) . Analysis of LMP2B has been difficult because of its hydrophobic nature and the lack of a specific anti-LMP2B antiserum. Here, we showed an initial characterization of LMP2B using fluorescent tags to visualize the protein in transiently expressing live and fixed cells. Tagged LMP2B localized to perinuclear membrane compartments in transiently transfected cells (Fig. 2) . Localization was not altered by the time post-transfection that the observations were made, the level of LMP2B fluorescence in the transfected cell or the type of cell (lymphocyte or epithelial) receiving the expression vector. Neither was localization altered by which tag (DsRed or EGFP) was present nor where the tags were fused (N or C terminus) onto the LMP2B molecule. LMP2B molecules with FLAG epitope tags had identical localizations. LMP2B molecules with FLAG epitope tags in extracellular loop1 and fluorescent domains fused at the C-terminal end had the same pattern of localization. These results suggest that the tags were not influencing where the LMP2B molecules localized and that the LMP2B sequences in all the tagged molecules were responsible for directing the perinuclear localization. The epitope tags could not be detected on the outside of unpermeabilized cells.
Previous studies showing LMP2A immunofluorescence have described the presence of aggregated proteins and implicated the plasma membrane as a significant site of (Longnecker et al., 1991 ; Longnecker & Kieff, 1990) . Those studies showed no live cell localizations, colocalization with surface markers or detection of the protein in unpermeabilized cells. Nevertheless, differences in the localization of LMP2A and LMP2B would have important implications for the functional role of LMP2B. Our analysis of transiently co-expressed LMP2A and LMP2B proteins showed that there was a high degree of co-localization observed when recombinant LMP2A and LMP2B plasmids were co-transfected into BJAB or 293T cells and viewed simultaneously by live cell fluorescence microscopy. When LMP2B-DsRed was transiently transfected into B95-8CR cells, more than 95 % of LMP2B co-localized with the endogenously expressed LMP2A. In these cells, at least one quarter of endogenous LMP2A was not co-localized with LMP2B. This could reflect a real difference in the localization of LMP2A. Since these cells had pre-existing LMP2A proteins at the time that they were transfected, it is possible that only LMP2A synthesized de novo in the post-transfection period was co-localizing with LMP2B. It is possible that only when the two proteins are being made together is LMP2B able to restrict the trafficking of LMP2A. The very high degree of co-localization seen in co-transfection experiments is consistent with this scenario.
LMP2A in the absence of LMP2B might be able to traffic within the endomembrane system and work its way to the surface. The notable difference in LMP2A and LMP2B localization was the significant co-localization of endogenous LMP2A with EEA-1, an endosomal marker in B95-8CR cells. A similar association was not detected in any LMP2B-transfected cells. This is consistent with a less restricted movement for LMP2A in the absence of LMP2B and leaves open the possibility that some of these molecules are surface bound. However, experiments with the loop1-tagged LMP2A and LMP2B proteins suggest that less than 1 % of the detectable LMP2 proteins are on the surface. The appearance of the LMP2A truncation mutants spread across the surface of the transfected cells indicated that the loop1 epitopes are readily detectable when they are in plasma membranes and that an intracellular retention phenotype is associated with sequences in the LMP2 transmembrane domain.
Markers for cellular membrane compartments were used to refine the intracellular location of LMP2B. The most significant co-localization was detected with a protein marker for the trans-Golgi network (γ-adaptin, a scaffolding component involved in vesicle budding from the Golgi endomembrane system). Both epi-fluorescence and confocal sectioning showed the same high degree of localization. There was a detectable, albeit much lower, level of co-localization with BIP-1. These fluorescence results suggest that we might be detecting the synthesis of LMP2B on ER membranes and a very slow movement of LMP2B to and through the Golgi relative to LMP2A, where there is less than 1 % BIP-1 association detected. LMP2B then appears to be deposited into an intracellular perinuclear vesicular membrane compartment.
Evidence for an association of LMP2B with endosomes or lysosomes was not obtained. About 10 % of the LMP2B fluorescence was associated with CD19 in an apparent contradiction to the finding that there was no surface fluorescence from loop1 epitope-tagged LMP2B. Confocal sectioning revealed that the CD19 fluorescence associated with LMP2B was intracellular and perinuclear. LMP2A did not show a similar CD19 co-localization. In contrast to LMP2B, more than half of the LMP2A fluorescence was found associated with the endosomal membrane compartment. Further studies are required to determine if this association represents an important difference in the trafficking of LMP2A and LMP2B.
Our studies show that when co-expressed with LMP2A, LMP2B co-localizes and probably associates with LMP2A in the same compartment within the cell. Neither protein seemed to redirect or dramatically influence the localization of the other molecule. In addition, neither protein showed a pattern of fluorescence consistent with a significant plasma membrane localization or surface presence. Our fluorescence microscopy studies included more controls, more cell lines and more LMP2 constructs than earlier reports. We have performed confocal microscopy studies clearly showing the absence of recombinant LMP2B and LMP2A localization to the surface and a lack of co-localization on the surface with a cell surface marker, CD19. A recent report by C. W. Dawson that used different cells and tagged LMP2 proteins reached similar conclusions (Dawson, 2001 ). In the main finding of their study of epithelial cells, LMP2A and LMP2B were described as intracellular and perinuclear. The conclusions about the sub-cellular compartment localization were not identical to ours but different compartment markers were employed so direct comparison is problematic. In our study, both lymphocytes and epithelial cells are presented and the results from the two cell types are consistent. Taken together, the evidence from the two studies indicates that the LMP2 proteins rarely visit the plasma membrane and that sequences within the transmembrane domain retain the molecules within intracellular membrane compartments. Intracellular localization is compatible with previous genetic and biochemical studies of LMP2 function. It is now necessary to determine what factors affect the localization of LMP2 proteins and whether alterations in the environment of a virus-infected cell change the localization. It will also be important to determine the extent to which LMP2 protein localization affects the localization and functioning of receptors and signal transducers. An intracellular destination for a latency-associated membrane protein offers intriguing possibilities for the control of the latent state and for the triggering mechanism for reactivation of the lytic cycle.
